Phase II trial of weekly docetaxel/irinotecan combination in advanced pancreatic cancer.
Burtness B, Thomas L, Sipples R, McGurk M, Salikooti S, Christoforou M, Mirto G, Salem R, Sosa J, Kloss R, Rahman Z, Chung G, Lacy J, Murren JR.
Burtness B, et al.
Cancer J. 2007 Jul-Aug;13(4):257-62. doi: 10.1097/PPO.0b013e31813c1174.
Cancer J. 2007.
PMID: 17762761
Clinical Trial.